CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980373793
- Phone
- 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- Open-market buys, last 90 days
- $120,435
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$120,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-12-31 | NJTC INVESTMENT FUND, LP 10% owner | Grant or award · Stock Option (right to buy) | +4,080 | 4,080 | ||
| 2010-12-31 | Rubin Joseph Director | Grant or award · Stock Option | +100,000 | 325,617 | ||
| 2010-12-31 | Jones Edward Raymond Director | Grant or award · Stock Option | +100,000 | 282,500 | ||
| 2010-09-30 | NJTC INVESTMENT FUND, LP 10% owner | Grant or award · Stock Option (right to buy) | +80 | 80 | ||
| 2010-09-17 | Chan Phillip P. CEO and President | Grant or award · Convertible Note Plus Warrants | +100,000 | $10,000.00 | $1.0B | 6,568,858 |
| 2010-06-30 | NJTC INVESTMENT FUND, LP 10% owner | Grant or award · Stock Option (right to buy) | +80 | 80 | ||
| 2010-05-05 | BARTLETT ROBERT HAWES Chief Medical Officer | Grant or award · Stock Option | +900,000 | 1,125,000 | ||
| 2010-05-05 | Capponi Vincent Chief Operating Officer | Grant or award · Stock Option | +3,000,000 | 7,300,000 | ||
| 2010-05-05 | Chan Phillip P. CEO and President | Grant or award · Stock Option | +3,350,000 | 6,368,858 | ||
| 2010-05-05 | Lamadrid David Chief Financial Officer | Grant or award · Stock Option | +2,750,000 | 7,850,000 | ||
| 2010-03-31 | NJTC INVESTMENT FUND, LP 10% owner | Grant or award · Stock Option (right to buy) | +80 | 80 | ||
| 2010-01-04 | Chan Phillip P. Interim Chief Executive Office | Grant or award · Stock Option | +500,000 | 3,018,858 | ||
| 2010-01-04 | Lamadrid David Chief Financial Officer | Grant or award · Stock Option | +400,000 | 5,100,000 | ||
| 2010-01-04 | Capponi Vincent Chief Operating Officer | Grant or award · Stock Option | +500,000 | 4,300,000 | ||
| 2010-01-04 | BARTLETT ROBERT HAWES Chief Medical Officer | Grant or award · Stock Option | +175,000 | 225,000 | ||
| 2010-01-01 | NJTC INVESTMENT FUND, LP 10% owner | Grant or award · Stock Option (right to buy) | +4,320 | 4,320 | ||
| 2009-12-31 | Jones Edward Raymond Director | Grant or award · Stock Option | +100,000 | 182,500 | ||
| 2009-12-31 | Rubin Joseph Director | Grant or award · Stock Option | +100,000 | 246,715 | ||
| 2009-12-31 | Kraus Al Director | Grant or award · Stock Option | +100,000 | 8,763,370 | ||
| 2009-11-20 | Lamadrid David Chief Financial Officer | Sale | −505,000 | $0.17 | $87K | 3,734 |
Page 36 of 39 · 774 trades